Oxidative stress, antioxidants and hypertension

M Amponsah-Offeh, P Diaba-Nuhoho, S Speier… - Antioxidants, 2023 - mdpi.com
As a major cause of morbidity and mortality globally, hypertension remains a serious threat
to global public health. Despite the availability of many antihypertensive medications …

[HTML][HTML] Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies

D Das, NR Shruthi, A Banerjee, G Jothimani… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Metabolic syndrome (MetS) is a multifaceted condition that increases the possibility of
developing atherosclerotic cardiovascular disease. MetS includes obesity, hypertension …

Cardiorenal Effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected …

PJ Baptiste, AYS Wong, A Schultze, CM Clase… - medRxiv, 2022 - medrxiv.org
Background Cardiovascular disease (CVD) is a leading cause of death globally.
Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) …

Triglyceride Glucose-Waist Circumference Is Superior to Other Biochemical Indicators for Diagnosing Prehypertension and Hypertension

VJ Vera-Ponce, RA Garcia-Lara… - … of Endocrinology and …, 2023 - jofem.org
Background: In situations with economic issues and limited resources, prevention and early
detection of hypertension are essential for its control. Diagnosis and treatment require …

[PDF][PDF] Real-world effectiveness and adverse events caused by ACE inhibitors and ARBs for reduction in cardiovascular events with validation against the ONTARGET …

PJ BAPTISTE - 2023 - scholar.archive.org
LSHTM Research Online Page 1 LSHTM Research Online Baptiste, PJ; (2023) Real-world
effectiveness and adverse events caused by ACE inhibitors and ARBs for reduction in …